The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 15.30
Cancer of the Lung and Bronchus (Invasive)
| Histologya | All Races | White | Black | Asian/ Pacific Islander |
American Indian /Alaska Nativeb |
Hispanicc | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Count | Percent | Count | Percent | Count | Percent | Count | Percent | Count | Percent | Count | Percent | |
| Carcinoma | 104,627 | 98.9% | 88,088 | 98.9% | 10,682 | 98.8% | 5,150 | 99.0% | 350 | 97.8% | 5,590 | 98.0% |
| Small cell (8041-8045) | 15,338 | 14.5% | 13,618 | 15.3% | 1,280 | 11.8% | 317 | 6.1% | 77 | 21.5% | 659 | 11.6% |
| Non-small celld | 89,289 | 84.4% | 74,470 | 83.6% | 9,402 | 87.0% | 4,833 | 92.9% | 273 | 76.3% | 4,931 | 86.4% |
| Squamous and transitional celle | 17,870 | 16.9% | 15,240 | 17.1% | 2,029 | 18.8% | 489 | 9.4% | 72 | 20.1% | 781 | 13.7% |
| Adenocarcinomaf | 47,593 | 45.0% | 39,246 | 44.1% | 4,703 | 43.5% | 3,357 | 64.5% | 116 | 32.4% | 2,821 | 49.5% |
| Large cell (8011-8015) | 2,533 | 2.4% | 2,098 | 2.4% | 338 | 3.1% | 79 | 1.5% | - | - | 112 | 2.0% |
| Other non-small cellg | 21,293 | 20.1% | 17,886 | 20.1% | 2,332 | 21.6% | 908 | 17.4% | 76 | 21.2% | 1,217 | 21.3% |
| Sarcomah | 193 | 0.2% | 155 | 0.2% | 22 | 0.2% | - | - | - | - | 24 | 0.4% |
| Other specified typesi | 76 | 0.1% | 60 | 0.1% | - | - | - | - | - | - | - | - |
| Unspecified (8000-8005) | 867 | 0.8% | 723 | 0.8% | 94 | 0.9% | 41 | 0.8% | - | - | 81 | 1.4% |
| Total | 105,763 | 100.0% | 89,026 | 100.0% | 10,812 | 100.0% | 5,204 | 100.0% | 358 | 100.0% | 5,704 | 100.0% |
Footnotes:
Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.
a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.
b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.
c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.
d Non-small cell includes histologies 8010-8015, 8020-8022, 8030-8040, 8046, 8050-8052, 8070-8084, 8090-8110, 8120-8131, 8140-8156, 8160-8162, 8170-8175, 8180, 8190-8221, 8230-8231, 8240-8263, 8270-8280, 8290-8337, 8340-8347, 8350-8390, 8400-8562, 8570-8576, 8580-8671, 8940-8941.
e Squamous and transitional cell includes histologies 8051-8052, 8070-8084, 8120-8131.
f Adenocarcinoma includes histologies 8050, 8140-8149, 8160-8162, 8190-8221, 8250-8263, 8270-8280, 8290-8337, 8350-8390, 8400-8560, 8570-8576, 8940-8941.
g Other non-small cell includes large cell carcinoma, NOS, other specified carcinomas, and unspecified carcinomas. Other non-small cell is defined as histologies 8010, 8020-8022, 8030-8040, 8046, 8090-8110, 8150-8156, 8170-8175, 8180, 8230-8231, 8240-8249, 8340-8347, 8561-8562, 8580-8671.
h Sarcoma includes histologies 8680-8713, 8800-8921, 8990-8991, 9040-9044, 9120-9136, 9150-9252, 9370-9373, 9540-9582.
i Other specific types includes melanomas and is defined as histologies 8720-8790, 8930-8936, 8950-8983, 9000-9030, 9060-9110, 9260-9365, 9380-9539.
- Statistic not shown due to fewer than 16 cases during the time period.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.